DCBLD2 and hypopharynx squamous cell carcinoma: DCBLD2 overexpression has also been reported in glioblastomas, hypopharyngeal squamous cell carcinoma, and invasive myxofibrosarcoma; however, its expression is inconsistent in different tumors.